Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on advancing innovative cancer therapies, with a pipeline that includes both immune-oncology and targeted treatments designed to transform patient outcomes. Based in Hayward, California, Arcus is leveraging its proprietary platforms and strategic partnerships to develop therapies that harness the body's immune system against tumors. With a commitment to enhancing cancer care, the company is positioned for significant growth as it progresses its candidates through clinical trials and prepares for potential commercialization.